Viewpoint Molecular Targeting Overview

  • Founded
  • 2008
Founded
  • Status
  • Private
  • Latest Deal Type
  • Angel
  • Latest Deal Amount
  • $750K
Latest Deal Amount
  • Investors
  • 3

Viewpoint Molecular Targeting General Information

Description

Developer of pharmaceutical drugs intended for diagnostic imaging and therapy for cancer, with a focus on metastatic melanoma. The company's product can be used to determine the location and extent of cancerous tumors in the body, enabling the health professionals to direct a lethal dose of radiation precisely to cancer cells in the body.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Pharmaceuticals
Primary Office
  • 2500 Crosspark Boulevard
  • Coralville, IA 52241
  • United States
+1 (865) 000-0000

Viewpoint Molecular Targeting Timeline

2017201820192020
Financing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Viewpoint Molecular Targeting Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Angel (individual) 17-Jun-2020 $750K 00000 Completed Pre-Clinical Trials
2. Grant 08-Sep-2017 000 Completed Pre-Clinical Trials
1. Grant 31-Aug-2016 $1.2M Completed Startup
To view Viewpoint Molecular Targeting’s complete valuation and funding history, request access »

Viewpoint Molecular Targeting Executive Team (3)

Name Title Board Seat Contact Info
Heyward Coleman Board Member and Chief Executive Officer
Michael Schultz Ph.D Co-Founder, Board Member and Chief Science Officer
Frances Johnson MD Co-Founder, Board Member and Chief Medical Officer
To view Viewpoint Molecular Targeting’s complete executive team members history, request access »

Viewpoint Molecular Targeting Board Members (4)

Name Representing Role Since
Curtis Nelson Viewpoint Molecular Targeting Board Member 000 0000
Frances Johnson MD Viewpoint Molecular Targeting Co-Founder, Board Member and Chief Medical Officer 000 0000
Heyward Coleman Viewpoint Molecular Targeting Board Member and Chief Executive Officer 000 0000
Michael Schultz Ph.D Viewpoint Molecular Targeting Co-Founder, Board Member and Chief Science Officer 000 0000
To view Viewpoint Molecular Targeting’s complete board members history, request access »

Viewpoint Molecular Targeting Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Cancer Institute Government 000 0000 000000 0
Iowa Economic Development Authority Government 000 0000 000000 0
NIH Small Business Innovation Research Government 000 0000 000000 0
To view Viewpoint Molecular Targeting’s complete investors history, request access »